Thyroid Function in Monozygotic Twins with Intra-twin Birth Weight Differences: A Prospective Longitudinal Cohort Study - 24/07/19

, Felix Schreiner, MD 1, Mathias Gruenewald 1, Rolf Fimmers, PhD 2, Birgit Stoffel-Wagner, MD, BS 3, Peter Bartmann, MD, PhD 4, Joachim Woelfle, MD 1Abstract |
Objective |
To analyze the long-term impact of birth weight (BW) on thyroid function in genetically identical twins with intra-twin BW differences from birth to adolescence.
Study design |
In total, 52 monozygotic twin pairs underwent at least one analysis of thyroid function at mean ages of 10.1 years (27 pairs), 15.1 years (35 pairs), and 17.4 years (36 pairs); 18 pairs donated blood at all time points. BW difference of <1 SDS was defined as concordant, BW difference ≥1 SDS as discordant.
Results |
In concordant twins, no significant differences were observed. In the discordant group, smaller twins had higher mean thyroid-stimulating hormone (TSH) than their larger co-twins at 10.1 years (3.6 vs 2.5 μU/mL; P = .04) and 15.1 years (2.6 vs 2.2 μU/mL; P = .08). Smaller twins showed lower mean thyroxine than larger co-twins at 10.1 years (7.8 vs 8.2 μg/dL P = .05) and 17.4 years (7.7 vs 8.4 μg/dL; P = .03), and a tendency at 15.1 years (6.9 vs 7.4 μg/dL; P = .09). Calculation of TSH-thyroxine ratio revealed significant differences in the discordant group, with greater ratios in the smaller twin at 10.1 years (0.5 vs 0.3; P = .006) and 15.1 years (0.4 vs 0.3; P = .04).
Conclusions |
In this group of monozygotic twins with intra-twin BW differences, BW seemed to exert a long-lasting impact on thyroid function. This may be due to a delay in hypothalamic−pituitary−thyroid axis maturation, with TSH resistance during childhood and early adolescence in children with low BW.
Le texte complet de cet article est disponible en PDF.Keywords : thyroid, birth weight, fetal programming
Abbreviations : AIC, AMR, BMI, BW, Δ, fT4, SGA, T3, T4, TBG, TgAb, TPOAb, TSH
Plan
| Supported by funding from the BMBF (FKZ01EA1410B [to J.W.] and an unrestricted study grant from Pfizer. The authors declare no conflicts of interest. |
Vol 211
P. 164 - août 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
